NADomics: Measuring NAD(+) and Related Metabolites Using Liquid Chromatography Mass Spectrometry

por Braidy, Nady, Villalva, Maria D., Grant, Ross
Publicado 2021

Sobriety and Satiety: Is NAD+ the Answer?

por Braidy, Nady, Villalva, Maria D., van Eeden, Sam
Publicado 2020

Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD

por Hedl, Thomas J., San Gil, Rebecca, Cheng, Flora, Rayner, Stephanie L., Davidson, Jennilee M., De Luca, Alana, Villalva, Maria D., Ecroyd, Heath, Walker, Adam K., Lee, Albert
Publicado 2019

Unbiased Label-Free Quantitative Proteomics of Cells Expressing Amyotrophic Lateral Sclerosis (ALS) Mutations in CCNF Reveals Activation of the Apoptosis Pathway: A Workflow to Scr...

por Cheng, Flora, De Luca, Alana, Hogan, Alison L., Rayner, Stephanie L., Davidson, Jennilee M., Watchon, Maxinne, Stevens, Claire H., Muñoz, Sonia Sanz, Ooi, Lezanne, Yerbury, Justin J., Don, Emily K., Fifita, Jennifer A., Villalva, Maria D., Suddull, Hannah, Chapman, Tyler R., Hedl, Thomas J., Walker, Adam K., Yang, Shu, Morsch, Marco, Shi, Bingyang, Blair, Ian P., Laird, Angela S., Chung, Roger S., Lee, Albert
Publicado 2021